Steering Committee

The CTTI Steering Committee (SC), made up of representatives from CTTI members across multiple sectors, provides input into decisions about CTTI priorities, projects and recommendations. Below, you will find a list of our SC members:

Murray Abramson, MD
VP Global Clinical Operations
Maria Ali, MBBS, MBA
Chief Medical Officer
Jeff Allen, PhD
Executive Director
Jaime Arango, EdD, CIP
Director, CITI Educational Initiatives

CITI Program, a Division of BRANY

Jimmy Bechtel
Senior Project Manager
Deirdre BeVard
SVP Strategic Operations
Jodi Black
Director Office of Clinical Policy and Programs, Office of the Commissioner
David Borasky, MPH, CIP
Vice President, Quality Management
Robyn Burns, PhD
Program Manager, MRFBC; Science Officer, MRF
Kathryn Capanna
Deputy Division Director for Science and Strategic Partnerships
David Ciavarella, MD
Vice President, Global Clinical Development
Linda Coleman
Director, Human Research Protection Program
Dan Cooper
Associate Vice Chancellor for Clinical and Translational Science
MarieElena Cordisco MA, NP-C, APRN, CCRC
Office of Clinical Trials, Department of Research and Innovation
Kristin Dolinski
Director, Science and Regulatory Advocacy
Scott Evans, PhD, MS
Harvard University, Senior Research Scientist
Gary Fanjiang, MD, MBA, MS
Executive Medical Director
Ari Feldman
Vice President, Global Compliance & Strategy
Beth Fraulo
Director of Operations for DCRI
Danielle Friend
Senior Director, Science and Regulatory Policy
Pat Furlong
James Gibaldi
Associate Director, Research Partnerships
Hernando Giraldo
US Regional Lead Digital Development, Global Clinical Operations
Jörg Goldhahn, MD
Head of the Institute for Translational Medicine at ETH Zurich, Switzerland
Courtney Granville
Global Associate Director, Research and Programs
Marie-Pierre Hellio Le Graverand-Gastineau, MD, DSc, PhD
Vice President and Head of Clinical Development and Operations, Global Product Development
Phil Green
Patient/Caregiver Representative
Judith Hochman, MD
Co-Director, NYU-HHC, CTSI
Grant Huang, MPH, PhD
Deputy Director, Cooperative Studies Program, Office of Research and Development
Patricia Hurley, MSc
Director of Strategic Research Initiatives
Cheryl Jernigan, CPA, FACHE
Volunteer Advocate/AIS Steering Committee Member
Daniel Karlin, MD
Chief Medical Officer
Hallie Kassan, MS, CIP
Director, Office of the HRPP
Jason Kim
Director Osteoarthritis Research Programs
Pete Knox
Senior Director of Research
Kerstin Koenig
Global Head Research & Development Quality at Bristol Myers Squibb
Michael Kurilla, MD-PhD
Director, Division of Clinical Innovation, NCATS
Martin Landray, PhD, FRCP
Professor of Medicine & Epidemiology; Clinical Trial Service Unit & Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford
Andy Lee
Senior Vice President, Head of Global Clinical Trials Operations
Patrick Lee, MD
Xavier Lefebvre
Global Vice President
Joanne Less, PhD
Director, Good Clinical Practice Program
Michael Lincoff, MD
Director, Center for Clinical Research; Director, Cleveland Clinic Coordinating Center for Clinical Research (C5 Research)
Beverly Lorell, MD, FACC
Senior Medical & Policy Advisor
Elizabeth Luczak
VP Global QMS and Compliance
Jerry Menikoff, MD, JD
Kristen Miller, PharmD
Health Science Policy Analyst, OMP
Jules Mitchel, MBA, PhD
Hiromasa Mori
Head of Neurology Patient Technology Europe


David Nickerson
Head, Clinical Quality Management
Virginia Nido
Head, Industry Collaborations Management, Product Development, Global External Collaborations
Nuru Noor
Patient/Caregiver Representative
Ingrid Oakley-Girvan, PhD, MPH
SVP of Research and Strategy
Kelley O'Donoghue, MPH, CIP
Executive Director, Research Subjects Review Board
Janette Panhuis, BScN, MBA
Chief Executive Officer
Lora Parahovnik
Jahmeilia Paul, MPH, CHES
Manager, Patient Education
Lynne Quittell, MD
Vice Chair Data Safety Monitoring Board
Jamil Rivers
Patient/Caregiver Representative
Matthew Roche
Director, Outcomes Research
Matthew Roe, MD
Chief Medical Officer
James Rollins, MD
Director of the Division of Items and Devices; Coverage and Analysis Group
Daniel Rose, MD
Senior Advisor
Ronenn Roubenoff, MD, MHS
Global Head, Musculoskeletal Translational Medicine
Albert T. Roy
Executive Director
Michele Russell-Einhorn, JD
Chief Compliance Officer and Institutional Official
Kristin Schneeman
Director of Programs
Karlin Schroeder, MA
Associate Vice President, Community Engagement
Nicole Sheetz, PharmD
Director, Data Driven Design, Enrollment, TMF/Records Management & Decentralized Trial Capabilities Clinical Design, Delivery & Analytics (CDDA)
Jeffrey Sherman, MD, FACP
Chief Medical Officer
Priscilla Short, BHA, CIP, CCRP
Executive Director
Theresa Strong, PhD
Director of Research Programs
Janet Trunzo
Senior Executive Vice President
Tracy Vanderslice
Vice President of Global Clinical Sciences & Delivery
Meghan Wagner
Health Scientist, Pharmacy Outcomes Research
Scott Weir
Director, The Institute for Advancing Medical Innovation
Neil Weissman, MD
Tiffany Westrich-Robertson
CEO, Director of Patient Engagement
Alcia Williams, MD, MPH, Capt USPHS
Deputy Associate Director for Science, National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention
Craig Wozniak
Vice President, Trial Coordination & Site Management-Americas
Jeremy Wyatt